Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil?

Tomljenovic L, Shaw CA.

J Intern Med. 2012 Nov;272(5):514-5; author reply 516. doi: 10.1111/j.1365-2796.2012.02551.x. No abstract available.

2.

Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.

Grimaldi-Bensouda L, Guillemot D, Godeau B, Bénichou J, Lebrun-Frenay C, Papeix C, Labauge P, Berquin P, Penfornis A, Benhamou PY, Nicolino M, Simon A, Viallard JF, Costedoat-Chalumeau N, Courcoux MF, Pondarré C, Hilliquin P, Chatelus E, Foltz V, Guillaume S, Rossignol M, Abenhaim L; PGRx-AID Study Group..

J Intern Med. 2014 Apr;275(4):398-408. doi: 10.1111/joim.12155.

3.

Safety of quadrivalent human papillomavirus vaccine.

Omer SB.

J Intern Med. 2012 Feb;271(2):177-8. doi: 10.1111/j.1365-2796.2011.02481.x. No abstract available.

4.

Quadrivalent HPV vaccination reactions--more hype than harm.

Douglas RJ.

Aust Fam Physician. 2009 Mar;38(3):139-42.

5.

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years.

Einstein MH, Baron M, Levin MJ, Chatterjee A, Edwards RP, Zepp F, Carletti I, Dessy FJ, Trofa AF, Schuind A, Dubin G; HPV-010 Study Group..

Hum Vaccin. 2009 Oct;5(10):705-19.

PMID:
19684472
6.

Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine.

Chao C, Klein NP, Velicer CM, Sy LS, Slezak JM, Takhar H, Ackerson B, Cheetham TC, Hansen J, Deosaransingh K, Emery M, Liaw KL, Jacobsen SJ.

J Intern Med. 2012 Feb;271(2):193-203. doi: 10.1111/j.1365-2796.2011.02467.x.

7.
8.

HPV vaccines and autoimmune diseases.

Shoenfeld Y.

J Intern Med. 2012 Jul;272(1):98; author reply 99. doi: 10.1111/j.1365-2796.2012.02537.x. No abstract available.

9.

CNS demyelination and quadrivalent HPV vaccination.

Sutton I, Lahoria R, Tan I, Clouston P, Barnett M.

Mult Scler. 2009 Jan;15(1):116-9. doi: 10.1177/1352458508096868.

PMID:
18805844
10.

The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil.

Haupt RM, Sings HL.

J Adolesc Health. 2011 Nov;49(5):467-75. doi: 10.1016/j.jadohealth.2011.07.003.

PMID:
22018560
11.

HPV vaccines and pregnancy: the situation in early 2012.

[No authors listed]

Prescrire Int. 2012 Jun;21(128):154-7. Review.

PMID:
22822594
12.

Efficacy of human papillomavirus vaccines: a systematic quantitative review.

Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC, Zanini RR.

Int J Gynecol Cancer. 2009 Oct;19(7):1166-76. doi: 10.1111/IGC.0b013e3181a3d100. Review.

PMID:
19823051
13.

The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).

Ansstasiou-Fotaki P, Deligeoroglou E, Kreatsas G.

Akush Ginekol (Sofiia). 2007;46(3):17-20. Bulgarian, English.

PMID:
18018777
14.

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

Reisinger KS, Block SL, Lazcano-Ponce E, Samakoses R, Esser MT, Erick J, Puchalski D, Giacoletti KE, Sings HL, Lukac S, Alvarez FB, Barr E.

Pediatr Infect Dis J. 2007 Mar;26(3):201-9.

PMID:
17484215
15.

Gardasil: Introducing the new human papillomavirus vaccine.

McLemore MR.

Clin J Oncol Nurs. 2006 Oct;10(5):559-60.

PMID:
17063609
16.

Human papillomavirus vaccines.

Schmiedeskamp MR, Kockler DR.

Ann Pharmacother. 2006 Jul-Aug;40(7-8):1344-52. Review.

PMID:
16849621
17.

Safety of the quadrivalent human papillomavirus vaccine.

Brotherton JM.

BMJ. 2013 Oct 9;347:f5631. doi: 10.1136/bmj.f5631. No abstract available.

PMID:
24108153
18.

Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy.

Ojaimi S, Buttery JP, Korman TM.

Vaccine. 2009 Aug 6;27(36):4876-8. doi: 10.1016/j.vaccine.2009.06.026.

PMID:
19555713
19.

Assessing human papillomavirus vaccine efficacy and safety.

Hendrix SL.

J Am Osteopath Assoc. 2008 Apr;108(4 Suppl 2):S8-S12. Review.

PMID:
18463363
20.

HPV vaccination - a paradigm shift in public health.

May J.

Aust Fam Physician. 2007 Mar;36(3):106-11.

Items per page

Supplemental Content

Support Center